LYPD1 rs11702307: Understanding Your Genetic Anxiety Association
The rs11702307 variant is a single nucleotide polymorphism located within the LYPD1 gene, also known as LYNX2. Research suggests this genetic marker is associated with individual differences in anxiety levels and how the body responds to perceived threats.
What each genotype means
Typical anxiety response profile
This genotype represents the common genetic background at this location in the LYPD1 gene. Research suggests this variant may modulate how the brain processes threats, but current evidence is limited to initial association studies. This finding should not be used to predict individual mental health outcomes or diagnose anxiety disorders.
This is the most common genotype observed in general population studies.
Potential anxiety-associated variant
Carrying this genotype means you possess one copy of the variant associated with altered protein binding to nicotinic acetylcholine receptors in the brain. While studies have linked this variant to differences in anxiety levels, the clinical significance remains under investigation. Please consult with a mental health professional if you have concerns about your psychological well-being.
This genotype is found at a low frequency across global populations, appearing in a small minority of individuals.
Potential anxiety-associated variant
Carrying two copies of this variant may influence how your brain responds to perceived threats by affecting LYPD1 protein function. Current research indicates an association with anxiety, though the effect size and real-world impact are still being defined by the scientific community. This information is for educational purposes and is not a medical diagnosis.
This genotype is rare, occurring in a very small fraction of the general population.
What is rs11702307?
The rs11702307 variant is a specific location in the human genome where a single nucleotide change can occur. In the context of genetic research, this is known as a single nucleotide polymorphism, or SNP. This particular SNP is situated within the LYPD1 gene, which provides instructions for producing a protein that plays a role in the nervous system. Scientists study these variations to understand how small differences in our DNA sequence might contribute to complex human traits, such as temperament or susceptibility to anxiety. Because this variant is located in a region of the gene that may influence protein function, it has become a subject of interest for researchers investigating the biological underpinnings of psychological health. It is important to note that having a specific genotype at this location does not determine a person's mental health status, but rather represents a statistical association observed in research cohorts.
The Role of the LYPD1 Gene
The LYPD1 gene, often referred to as LYNX2, encodes a protein that is part of the Ly6/uPAR family. These proteins are known to interact with nicotinic acetylcholine receptors in the brain. These receptors are critical for communication between neurons and are involved in various cognitive and physiological processes. Research indicates that the protein produced by LYPD1 may modulate the activity of these receptors, potentially influencing how the brain processes signals related to stress and threat. By altering the binding affinity or the signaling efficiency of these receptors, variations in the LYPD1 gene could theoretically impact the intensity of an individual's physiological response to environmental stressors. Understanding this mechanism is a focus of ongoing neurobiological research, as it helps bridge the gap between genetic sequence variations and observable behavioral phenotypes related to anxiety.
Evidence and Anxiety Associations
Current research has identified a statistical association between the rs11702307 variant and anxiety-related traits. In a study involving a cohort of 624 participants, researchers examined how variations in the LYPD1 gene might correlate with anxiety levels. The findings suggest that this SNP may influence the protein's ability to bind to nicotinic acetylcholine receptors, which in turn may modulate psychological and physiological responses to perceived threats. While these results are intriguing, the evidence strength is currently considered moderate. It is essential to recognize that anxiety is a complex, polygenic trait influenced by a vast array of genetic, environmental, and developmental factors. A single SNP like rs11702307 provides only a very small piece of a much larger puzzle. Further large-scale, multi-ancestry studies are required to confirm these findings and to understand how this variant interacts with other genetic and non-genetic factors to influence human behavior.
Interpreting Your Genetic Information
When you encounter information about genetic variants like rs11702307, it is important to maintain a balanced perspective. This information is intended for educational purposes and should not be used to diagnose, treat, or predict any medical condition. Genetic associations are based on population-level statistics and do not provide a definitive prediction for any single individual. If you are concerned about anxiety or your mental health, the most effective approach is to consult with a qualified healthcare professional or a mental health specialist. They can provide a comprehensive evaluation that considers your personal history, symptoms, and overall well-being. Do not make any changes to your health regimen or medication based on genetic test results without first discussing them with your clinician. Genetic data is a tool for scientific discovery, but it is not a substitute for professional medical advice and clinical assessment.
How common is this variant?
Specific population frequency data for rs11702307 is not currently well-documented in major public databases. Frequency can vary significantly across different ancestral groups.
Frequently asked questions
Does having the rs11702307 variant mean I have an anxiety disorder?
No. Genetic variants are only one of many factors that contribute to anxiety. Having a specific genotype does not diagnose a disorder or guarantee that you will experience anxiety.
Can I use this SNP to predict my risk of anxiety?
Current research does not support using this SNP for clinical risk prediction. Anxiety is a complex trait influenced by many genes and environmental factors, making individual prediction based on one SNP unreliable.
Where can I find more information about LYPD1?
You can search for the LYPD1 gene on resources like the NCBI Gene database or MedlinePlus Genetics. These sites provide comprehensive information on gene function and related research.
Should I change my medication based on this genetic result?
Absolutely not. You should never change your medication or treatment plan based on genetic information without consulting your doctor or pharmacist. Always discuss your genetic results with a healthcare professional.
Sources & further reading
Educational information only, last refreshed 9/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs11702307?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29